Saliva
Hst-5 (μg/ml)
% killing
HIV+ (M)
4.82*
18.62
HIV+ (L)
1.1
0
HIV- (H)
8.67*
35.86
HIV- (M)
5.62*
19.31
HIV- (L)
2.6
0
Experiments were performed on three separate occasions. (L) % killing was compared with rest of the groups. * P<0.05
Table 3:
Anti-candidal potency of characterized pooled saliva from the HIVand HIV+ groups.
Goto home»
